Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 21, 2012 - Issue 5
Submit an article Journal homepage
984
Views
33
CrossRef citations to date
0
Altmetric
Reviews

Inhibition of pre-protein convertase serine kexin-9 (PCSK-9) as a treatment for hyperlipidaemia

Anthony S WierzbickiSt. Thomas' Hospital Campus, Department of Chemical Pathology, Lambeth Palace Road, London SE1 7EH, UK+0207 188 1256; +0207 188 7325; [email protected]
, DM DPhil FRCPath FAHA,
Timothy C HardmanNiche Science & Technology, London House, 243-253 Lower Mortlake Road, Richmond-Upon-Thames, London TW9 2LL, UK
, PhD &
Adie ViljoenLister Hospital, Consultant in Metabolic Medicine/Chemical Pathology, Stevenage, Hertfordshire SG1 4AB, UK
, MBBS FRCPath
Pages 667-676 | Published online: 12 Apr 2012

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.